首页/数据集/Comparisons of the mean of EDSSp post-interferon-β therapy between groups.

Comparisons of the mean of EDSSp post-interferon-β therapy between groups.

NIAID Data Ecosystem2026-03-08 收录

数据链接：

https://figshare.com/articles/dataset/_Comparisons_of_the_mean_of_EDSSp_post_interferon_946_therapy_between_groups_/1042068 数据链接链接失效反馈

官方服务：

资源简介：

Comparisons of the mean of EDSSp post-interferon-β therapy between groups.

应用场景：

创建时间：

2014-06-02

多发性硬化症治疗评估

神经认知功能

*p<0.05; **p<0.001; EDSS = Expanded Disability Status Scale; FSS = Fatigue Severity Scale; HADS = Hospital Anxiety and Depression Scale; TIB–errors = Brief Intelligence Test–Errors; TIB–IQ = Brief Int

NIAID Data Ecosystem60

Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab

多发性硬化症治疗评估

神经生活质量改善

Aim: To assess time to improvement in Quality of Life in Neurological Disorders (Neuro-QoL) domains for patients treated with natalizumab versus ocrelizumab. Methods: Patients enrolled in the MS PATHS

DataCite Commons2024-05-17 更新30

Results of the multiple variables Cox’s regression analysis.

生存分析

多发性硬化症治疗评估

ARR: annualized relapse rate; ARR-MRI: annualized MRI relapse rate; HR: hazard ratio; SE: standard error; 95%CI: 95% confidence interval.

Figshare2018-10-23 更新20

A survey of risk tolerance to multiple sclerosis therapies

多发性硬化症治疗评估

投资者风险偏好

Objective: To determine tolerance to various risk scenarios associated with current MS therapies. Methods: People with MS from the North American Research Committee on Multiple Sclerosis (NARCOMS) Re

DataONE2020-06-24 更新30

Relationship between level of disability, bladder dysfunction, bowel dysfunction, and fatigue.

神经系统疾病关联

多发性硬化症治疗评估

EDSS: Expanded Disability Status Scale (range 1–10); MFIS: Modified Fatigue Impact Scale (range 1–84); ABSST: Actionable Bladder Symptom Screening Tool (range 1–24); RFIS: Revised Faecal Incontinence

NIAID Data Ecosystem20

Comparisons of the mean of EDSSp post-interferon-β therapy between groups.

资源简介：

相关数据集